QI
IFRX icon

QS Investors’s InflaRx IFRX Stock Holding History

QS Investors’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$517K Hold
174,200
– – 0.01% 725
2021
Q1 		$679K Buy
+174,200
New +$892K 0.01% 659

Other funds holding IFRX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

QS Investors's IFRX Position: Q2 2021 in Review

QS Investors held its InflaRx (IFRX) position steady in Q2 2021 at 174,200 shares worth $517K. The position accounts for 0.01% of the portfolio, ranked #725.

QS Investors first reported a position in IFRX in Q1 2021 and has held it in 2 quarters since. The position peaked at $679K in Q1 2021. 37 funds tracked by Wall St. Rank hold IFRX as of Q2 2021.

  • QS Investors held 174,200 shares of InflaRx worth $517K as of Q2 2021.
  • QS Investors left its InflaRx share count unchanged in Q2 2021.
  • InflaRx made up 0.01% of QS Investors's portfolio in Q2 2021, its #725 holding.
  • QS Investors first reported a position in InflaRx in Q1 2021 and has held it in 2 quarters since.
  • QS Investors's InflaRx position peaked at $679K in Q1 2021.
  • 37 funds tracked by Wall St. Rank held InflaRx as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.